ZAKARY CALL: Open Payments
NPI 1699323469 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 36 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $150 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $156 |
| Vanda Pharmaceuticals Inc. | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Lundbeck LLC | 3 | $70 |
| ABBVIE INC. | 4 | $61 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: REXULTI, CAPLYTA, FANAPT, VRAYLAR, Jornay PM, SPRAVATO, INVEGA, COBENFY.
Industry payments across AZ — which companies pay providers there.
